FDA official: Some patients will probably die if MS drug allowed on market

WASHINGTON (AP) - Dozens of multiple sclerosis patients asked federal health advisers Tuesday to let them decide whether to take Tysabri, a promising drug that was pulled from the market after it was linked to a rare, often-fatal brain infection....More